Sign in

CIK 0001453687

  • Non-accelerated filer
  • Smaller reporting company

Cartesian Therapeutics, Inc.

Sign in to watch
Ticker
RNAC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 301-348-8698
Business address
7495 NEW HORIZON WAY, FREDERICK, MD, 21703
Former names
SELECTA BIOSCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-01-02 DeSilva Nishan M Director Grant or award · Stock Option (Right to Buy) +75,000 75,000
2023-01-02 Johnston Lloyd P. Chief Operations Officer Grant or award +100,000 275,299
2023-01-02 Johnston Lloyd P. Chief Operations Officer Grant or award · Employee Stock Option (right to buy) +475,000 475,000
2023-01-02 Kishimoto Takashi Kei Chief Scientific Officer Grant or award +100,000 374,100
2023-01-02 Kishimoto Takashi Kei Chief Scientific Officer Grant or award · Employee Stock Option (right to buy) +475,000 475,000
2023-01-02 Sallin Aymeric Director Grant or award · Stock Option (Right to Buy) +75,000 75,000
2023-01-02 SPRINGER TIMOTHY A Director Grant or award · Stock Option (Right to Buy) +75,000 75,000
2023-01-02 TRABER PETER G Chief Medical Officer Grant or award +200,000 457,765
2023-01-02 TRABER PETER G Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +900,000 900,000
2023-01-02 ZENNER PATRICK J Director Grant or award · Stock Option (Right to Buy) +75,000 75,000
2022-12-05 Brunn Carsten President and CEO Sale −4,522 $1.33 $6K 544,283
2022-12-01 Brunn Carsten President and CEO Option exercise +10,938 548,805
2022-12-01 Brunn Carsten President and CEO Option exercise · Restricted Stock Units −10,938 0
2022-11-28 Davis Blaine Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +1,250,000 1,250,000
2022-09-28 Brunn Carsten President and CEO Sale −2,692 $1.66 $4K 537,867
2022-09-02 Brunn Carsten President and CEO Sale −4,768 $1.85 $9K 540,559
2022-09-01 Brunn Carsten President and CEO Option exercise +10,937 545,327
2022-09-01 Brunn Carsten President and CEO Option exercise · Restricted Stock Units −10,937 10,938
2022-06-13 COX CARRIE SMITH Director Purchase +130,000 $1.15 $150K 212,881
2022-06-01 Brunn Carsten President and CEO Option exercise +10,938 534,390

Page 20 of 25 · 495 trades